Becker's Healthcare August 20, 2024
Laura Dyrda

Walgreens is partnering with the Biomedical Advanced Research and Development Authority within HHS to accelerate innovation in decentralized clinical trials.

The Decentralized Clinical Operations for Healthcare Research program is designed to strengthen decentralized clinical research in support of FDA-regulated products. The federal government will have access to Walgreens’ clinical trial ecosystem, which is designed to make clinical trials more accessible. It has reached more than 5 million patients over the last two years.

Walgreens has helped clinical trials meet recruitment goals and surpassed national averages for diverse...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Clinical Trials, Govt Agencies, HHS, Partnerships, Pharma, Pharma / Biotech, Trends
Related Articles:
Roche Welcomes FDA Approvals for Injectable Versions of MS and Cancer Drugs
Pfizer says its experimental drug for deadly condition that causes appetite and weight loss in cancer patients shows positive trial results
Does PBM Market Share Vary by Payer Type?
Allowing Medicare to Negotiate Drug Prices Remains Broadly Popular Among Voters, Though Most Are Unaware of the Law and Its Projected Savings
Pharma Pulse 9/13/24: AI Adoption for Clinical Trial Design, Comparing Biologics and Biosimilars & more

Share This Article